WASHINGTON, March 19 -- The U.S. Environmental Protection Agency has released the following public communication dated Feb. 25, 2025, from the Alaska Oil and Gas Association: * * * To: Ms. Felica Davis U.S. Environmental Protection Agency davis.felica@epa.gov * * * Dear Ms. Davis: The Alaska Oil and Gas Association ("AOGA") appreciates the opportunity to provide these updated comments on the proposed changes to the Standards of Performance for New Stationary Sources and Emission Guideline more ST

WASHINGTON, March 20 -- The U.S. Environmental Protection Agency has released the following public communication dated March 6, 2025, from American Fuel and Petrochemical Manufacturers: * * * To: Mr. William Gallagher Office of Air Quality Planning & Standards U.S. Environmental Protection Agency 109 T.W. Alexander Drive P.O. Box 12055 Research Triangle Park, NC 27711 Attention: Docket ID No. EPA-HQ-OAR-2024-0303 Re: Request for Extension of Deadline for Comments on EPA's National Emiss more ST

WASHINGTON, March 19 -- The U.S. Environmental Protection Agency has released the following public communication dated March 5, 2025, from the Chemours Co., Wilmington, Delaware: * * * To: U.S. Environmental Protection Agency EPA Docket Center 1200 Pennsylvania Avenue NW Washington, DC 20460 Re: Vinyl Chloride; Draft Scope of the Risk Evaluation Under the Toxic Substances Control Act (TSCA); Notice of Availability and Request for Comment 90 FR 4738 (January 16, 2025) Docket: EPA-HQ-OPPT-2 more ST

WASHINGTON, March 19 -- The U.S. Environmental Protection Agency has released the following public communication on March 11, 2025, from Physicians for Social Responsibility: * * * To: Administrator Lee Zeldin U.S. Environmental Protection Agency 1200 Pennsylvania Avenue NW Washington, DC 20460 RE: Review of New Source Performance Standards for Stationary Combustion Turbines and Stationary Gas Turbines, Docket ID No. EPA-HQ-OAR-2024-0419 * * * Physicians for Social Responsibility (PSR) i more ST

WASHINGTON, March 20 -- The U.S. Environmental Protection Agency has released the following public communication dated March 6, 2025, from Vision Profile Extrusions USA Ltd.-Delmont: * * * To: Marcy Card, Ph.D. Existing Chemicals Risk Assessment Division (7403M) Office of Pollution Prevention and Toxics Environmental Protection Agency 1200 Pennsylvania Ave. NW Washington, DC 20460-0001 Re: Vision Profile Extrusions USA Limited-Delmont Comments on the Draft Scope of the Risk Evaluation fo more ST

WASHINGTON, March 19 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated March 10, 2025, from the American Association for Cancer Research: * * * To: Food and Drug Administration Division of Dockets Management 5630 Fishers Lane, Rm. 1061 Rockville, MD, 20842 Re: Docket No. FDA-2024-D-2402, "Considerations for Including Tissue Biopsies in Clinical Trials; Draft Guidance for Industry, Investigators, Institutio more ST

WASHINGTON, March 19 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated March 4, 2025, from the American Association for Respiratory Care: * * * To: Candace Nalls, MPH Dockets Management Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Re: Pulse Oximeters for Medical Purposes - Non-Clinical and Clinical Performance Testing, Labeling, and Premarket Submission Recommendations; Dr more ST

WASHINGTON, March 19 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated March 10, 2025, from the Association for Molecular Pathology: * * * To: Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA-2024-D-2707, Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency; Draft Gu more ST

WASHINGTON, March 19 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated March 10, 2025, from Laboratory Corporation of America Holdings: * * * To: Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA-2024-D-2402-02 Draft Guidance for Industry: Considerations for Including Tissue Biopsies in Clinical Trials * * * Ladies an more ST

WASHINGTON, March 19 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated March 7, 2025, from the MedTech Strategy Advisors: * * * MedTech Strategy Advisors commends the FDA for updating the pulse oximetry guidance to address disparate pulse oximeter performance observed across skin tones. However, there are opportunities for enhancement that will clarify the recommendations and provide the least burdensome pathw more ST

WASHINGTON, March 19 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated March 11, 2025, from the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard, Boston, Massachusetts: * * * To: Office of Women's Health (OWH) Office of Clinical Policy (OCLP) Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Devices and Radiologica more ST

WASHINGTON, March 19 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated March 10, 2025, from the National Center for Health Research: * * * Public Comment of National Center for Health Research Regarding Accelerated Approval and Considerations for Determining Whether a Confirmatory Trial is Underway (Docket No. FDA-2024-D-3334) The National Center for Health Research (NCHR) appreciates the opportunity to comme more ST

WASHINGTON, March 19 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated March 10, 2025, from Planned Parenthood Federation of America: * * * To: Michelle Tarver, M.D., Ph.D. U.S. Food & Drug Administration Center for Devices and Radiological Health Office of the Center Director 10903 New Hampshire Avenue WO66-5431 Silver Spring, MD 20993-0002 Re: Docket No. FDA-2023-N-4976 "Pulse Oximeters for Medical Pu more ST

WASHINGTON, March 19 -- The U.S. Department of Transportation Federal Highway Administration has released the following public communication dated March 4, 2025, from the Alaska Department of Transportation and Public Facilities: * * * Subject: RE: Alaska DOT&PF comments - Asset Management - NPRM - FHWA Docket No. FHWA-2024-0048 From: Saboundjian, Stephan (DOT) To: Clemons, Tashia (FHWA) Subject: Alaska DOT&PF comments - Asset Manageme more ST

WASHINGTON, March 19 -- The U.S. Department of Justice has released the following public communication dated March 3, 2025, from CSL Behring: * * * To: U.S. Department of Justice National Security Division FARA Unit 175 N Street NE Constitution Square Washington, DC 20002 Re: Amending and Clarifying Foreign Agents Registration Act Regulations, RIN 1124-AA00 To Whom It May Concern: On behalf of CSL, I am writing to express our concerns regarding the Department of Justice's (DOJ) proposed  more ST

WASHINGTON, March 19 -- The U.S. Department of Transportation National Highway Traffic Safety Administration has released the following public communication dated March 11, 2025, from the Truck and Engine Manufacturers Association, Chicago, Illinois: * * * To: Docket Management Facility, M-30 U.S. Department of Transportation 1200 New Jersey Avenue SE West Building, Room W12-140 Washington, DC 20590 RE: Docket No. NHTSA-2016-0001 * * * The Truck and Engine Manufacturers Association ("EM more ST

WASHINGTON, March 20 -- The Nuclear Regulatory Commission has released the following public communication dated Feb. 28, 2025, from the Breakthrough Institute. Here are excerpts: * * * Breakthrough Institute Comment on 10 CFR Part 53: Risk-Informed, Technology-Inclusive Regulatory Framework for Advanced Reactors (NRC-2019-0062) * * * The NRC is developing a new licensing framework for commercial nuclear reactors, as mandated by the Nuclear Energy Innovation and Modernization Act. It publish more ST

WASHINGTON, March 19 -- The U.S. Office of Personnel Management has released the following public communication dated March 10, 2025, from the American Federation of Government Employees: * * * To: U.S. Office of Personnel Management 1900 E Street, NW Washington, DC 20415-1000 employeeaccountability@opm.gov submitted via www.regulations.gov Re: AFGE/NVAC's Comments Concerning RIN 3206-AO71, Appeal Procedures for Recoupment of Awards, Bonuses, or Relocation Expenses Awarded or Approved for more ST

WASHINGTON, March 19 -- The U.S. Department of the Treasury Office of the Comptroller of the Currency has released the following public communication dated March 11, 2025, from the Wisconsin Bankers Association, Madison, Wisconsin: * * * To: Chief Counsel's Office, Attention: Comment Processing, Office of the Comptroller of the Currency 400 7th Street SW, Suite 3E-218, Washington, DC 20219 * Ann E. Misback, Secretary, Board of Governors of the Federal Reserve System 20th Street and  more ST